...
首页> 外文期刊>Lung. >Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion
【24h】

Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion

机译:胸水腺苷脱氨酶(ADA)预测恶性胸腔积液患者的生存率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Systemic and local inflammations have been described as relevant prognostic factors in patients with cancer. However, parameters that stand for immune activity in the pleural space have not been tested as predictors of survival in patients with malignant pleural effusion. The objective of this study was to evaluate pleural lymphocytes and Adenosine Deaminase (ADA) as predictors of survival in patients with recurrent malignant pleural effusion.
机译:全身和局部炎症已被描述为癌症患者的相关预后因素。然而,代表胸膜腔内免疫活性的参数尚未经过测试,可以作为恶性胸腔积液患者生存率的预测指标。这项研究的目的是评估胸膜淋巴细胞和腺苷脱氨酶(ADA)作为复发性恶性胸腔积液患者生存的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号